December 2024
The global targeted therapeutics market revenue reached USD 85.75 billion in 2025 and is predicted to attain around USD 146.32 billion by 2033 with a CAGR of 6.83%. The demand for targeted therapeutics is increasing due to the surge in the prevalence of cancer, leukemia, and lymphoma.
Targeted therapeutics or targeted therapy is a kind of medical treatment created to specifically attack and target cancer cells while decreasing the damage to healthy normal cells. This approach is crucial to precision medications, which cater to treatment based on the genetic profile of an individual's cancer. These therapies have a higher level of precision, hence causing less harm to healthy cells and offering improved efficiency and better treatment outcomes.
Surge in Contraceptive Injectable
In recent years, the use of injectable contraceptives has risen significantly. This is mostly due to their high efficacy. These contraceptives can be administered once a month or every three months and are also considered the safest ways to prevent unwanted pregnancy. Also, some injectables like Noristerat a very common in the country like the U.K. and the U.S., impacting positive market growth further.
Development of Biologics Sector
The development of the biologics sector is the major trend in the market, fuelling its growth. A main factor responsible for this is the growing demand for insulin, vaccines, modern medicines, and human growth hormones that are utilized to treat chronic diseases such as cancer. Furthermore, these biologics are mainly taken through the injectable route. Hence, this sudden surge in the biologics sector is driving market expansion.
Increasing Demand for Personalized Medicine
There is an increasing demand for personalized medicine in disease treatment, where therapies are catered to a patient's specific molecular profile. Small molecule therapies provide the potential for more accurate and personalized treatment options, by addressing the special properties of everyone.
Growing Demand for Effective Cancer Treatment
The market is being driven by many factors, one of which is a rise in demand for more efficient treatments for many disorders. Conditions such as genetic disorders, cancer, and autoimmune diseases have a substantial impact on a patient's quality of life and health. Hence targeted therapy has the potential to treat chronic diseases, also resulting in fewer side effects.
North America dominated the market in 2024. The dominance of the region can be attributed to the ongoing surge in the biologics industry along with the presence of major biotechnology companies in the region. Furthermore, increasing investment and government support to expand production facilities of biopharmaceutical is expected to drive demand for biologics in countries like the U.S. and Canada, thereby fuelling market growth. The major players in the regional market include Abbott Laboratories, GlaxoSmithKline plc., AVEO Pharmaceuticals, Inc., Merck Sharp & Dohme Corp, and Johnson & Johnson Services, Inc.
Asia Pacific is expected to grow at the fastest rate over the forecast period. The growth of the region can be credited to the rising consumer awareness regarding the availability of targeted therapies and the growing incidence of chronic diseases such as cancer. Moreover, the ongoing expansion of medical facilities and the increasing popularity of health insurance will likely boost market growth shortly.
Report Attribute | Key Statistics |
Market Revenue in 2025 | USD 85.75 Billion |
Market Revenue by 2033 | USD 146.32 Billion |
CAGR | 6.83% from 2025 to 2033 |
Quantitative Units | Revenue in USD million/billion, Volume in units |
Largest Marke | North America |
Base Year | 2024 |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
By Type
By Application
By Distribution Channel
Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/1358
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com| +1 804 441 9344
December 2024
January 2025
April 2024
January 2025